Françoise Baylis responds to the recently announced birth of the world’s first genome edited babies and raises concerns about the scientific practice and ethical accountability.
Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.
Jason Scott Robert suggests that the creation of part-human animals in stem cell biology may generate scientific confusion.
Françoise Baylis supports the proposed new regulations for reimbursement related to assisted human reproduction.
Andrea Frydl cautions Canadians about the harms of direct-to-consumer advertising for pharmaceuticals and offers advice for health care providers and policy makers.